![]() |
|
|
Vol. 287, Issue 3, 889-896, December 1998
Department of Pharmacology and Experimental Therapeutics, School of
Pharmacy (S.A.R., E.B.S., V.T., E.S., Y.G., P.L.), Faculty of Medicine,
The Hebrew University, Jerusalem, Israel
The effect of Pardaxin, a neurotoxin that induces neurotransmitter
release from neurons, on the arachidonic acid (AA) cascade was studied
in PC12 cells. Both native and the synthetic Pardaxin selectively
stimulated phospholipase A2 (PLA2) activity
(measured by [3H]AA release) in the presence as well as
in the absence of extracellular calcium. Pardaxin-stimulated
PLA2 activity was also evident in the increased formation
of lysophosphatidylcholine. Pardaxin analogs, lacking the
-helical
structure that is essential for insertion into the plasma membrane,
were ineffective in stimulating the AA cascade in PC12 cells. Pardaxin
stimulation of PLA2 was markedly inhibited by the
nonselective PLA2 inhibitors bromophenacyl bromide and
mepacrine, by methyl arachidonyl fluorophosphonate, a dual inhibitor of
calcium-dependent cytosolic PLA2 and the
calcium-independent PLA2 and by bromoenol
lactone[(E)-6-(bromoethylene)tetrahydro-3-(1-naphthalenyl-2H-pyran-2-one], a highly specific inhibitor of calcium-independent PLA2.
After Pardaxin treatment, there was increased release of AA metabolites produced by the cyclooxygenase pathway as expressed in an 8-fold increase of PGE2 release. The release of other eicosanoids,
such as 6-keto-PGF1
and thromboxane B2, was
also augmented. Pardaxin-induced PGE2 release was observed
in calcium-free medium and in the absence of any increase in cytosolic
calcium. Dexamethasone partially inhibited Pardaxin-induced
PGE2 release. This effect was reversed by the type II
corticosteroid receptor antagonist RU-38486. Our results indicate that
Pardaxin stimulates release of AA and eicosanoids, independently of
calcium, and suggest that calcium-independent PLA2 plays an
important role in Pardaxin stimulation of the AA cascade.
This article has been cited by other articles:
![]() |
N. Papo, M. Shahar, L. Eisenbach, and Y. Shai A Novel Lytic Peptide Composed of DL-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice J. Biol. Chem., May 30, 2003; 278(23): 21018 - 21023. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bloch-Shilderman, S. Abu-Raya, V. Trembovler, H. Boschwitz, A. Gruzman, M. Linial, and P. Lazarovici Pardaxin Stimulation of Phospholipases A2 and Their Involvement in Exocytosis in PC-12 Cells J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 953 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bloch-Shilderman, H. Jiang, S. Abu-Raya, M. Linial, and P. Lazarovici Involvement of Extracellular Signal-Regulated Kinase (ERK) in Pardaxin-Induced Dopamine Release from PC12 Cells J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 704 - 711. [Abstract] [Full Text] |
||||